Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Industry News

Affera, Inc. Announces Successful First-In-Human Use of SpherePVI Circumferential Pulmonary Vein Isolation Device Using Pulsed Field Energy

July 27, 2021

News Industry News

Conformal Medical's CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference

October 15, 2020

News Industry News

Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke

September 05, 2018

News Industry News TCT 2016

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

November 01, 2016

News Industry News

Silk Road Medical Announces CE Mark Approval and First Patients Treated with the Next Generation ENROUTE® Transcarotid Neuroprotection System

March 16, 2016

News Industry News

First Patient Successfully Enrolled into ROADSTER 2 Transcarotid Artery Revascularization (TCAR) Study

November 02, 2015

News Industry News

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

October 15, 2015

News Industry News

FDA strengthens warning on NSAID labels

July 10, 2015

News Industry News

Pre-Clinical Study Conducted at Mayo Clinic LOS ANGELES, NeuroSigma®, Inc. (NeuroSigma), a California-based life sciences company, today announced that results of an animal study of its Thin Film Nit

May 04, 2015

Advertisement

Affera, Inc. Announces Successful First-In-Human Use of SpherePVI Circumferential Pulmonary Vein Isolation Device Using Pulsed Field Energy

Conformal Medical's CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference

Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

Silk Road Medical Announces CE Mark Approval and First Patients Treated with the Next Generation ENROUTE® Transcarotid Neuroprotection System

First Patient Successfully Enrolled into ROADSTER 2 Transcarotid Artery Revascularization (TCAR) Study

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

FDA strengthens warning on NSAID labels

Pre-Clinical Study Conducted at Mayo Clinic LOS ANGELES, NeuroSigma®, Inc. (NeuroSigma), a California-based life sciences company, today announced that results of an animal study of its Thin Film Nit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content